COLORADO SPRINGS, Colo., March 18, 2014 /PRNewswire/ -- The Biosyntrx mission and core values are behind the creation of the Thornton Ophthalmic Humanitarian Laureate Awards for outstanding service by an individual, and to the organization he or she serves, that best reflect the passion and principles associated with authentic True North leadership.
Beginning May 1, 2014, the winner and the nonprofit ophthalmic organization he or she serves will be chosen by our Humanitarian Committee and granted cash awards.
The presentation of the awards and the acceptance will take place at a live ophthalmic education event or via an online presentation.
Biosyntrx strongly believes that appreciation, exploration and commitment to science, art, music, and humanities adds significantly to the global greater good and are important parts of the intellectual whole.
About Biosyntrx, Inc.: Biosyntrx is a ten year old Nutritional Biotechnology Company with emphasis on ophthalmic nutrition science, professional cross talk, and healthy lifestyle education. The primary Biosyntrx Eye Care Professional-recommended products are BioTears, a patented product that addresses the systemic nutrient needs of the dry eye patient, with millions of doses safely used by satisfied repeat customers, Macula Complete, a potent full-spectrum multiple designed for those concerned about AMD, cataract, diabetic retinopathy, glaucoma, lack of energy, and optimal full-body health, also with millions of doses safely used by satisfied repeat customers. Oculair, a less potent full-body multiple, SightC+ for those who want or need daily or occasional mega-doses of mineral-buffered vitamin C, Zeaxanthin-4 for those who wants a 4 mg stand-alone zeaxanthin product, and EpiCor, a clinically proven immune system modulator.
Registration for free Biosyntrx nutrition science Friday Pearls, Tasty Tuesday nutrient-dense recipes and our Sunday Morning from the Intersection of Science, Art, Music and Humanities is available on the Biosyntrx web site. www.biosyntrx.com
SOURCE Biosyntrx, Inc.